日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Evaluation of the effect of a cell penetrating peptide (TAT) towards tailoring the targeting efficacy and tumor uptake of porphyrin

评估细胞穿透肽 (TAT) 对调整卟啉靶向功效和肿瘤摄取的影响

期刊:RSC Medicinal Chemistry
影响因子:4.1
doi:10.1039/d2md00097k
Mohini Guleria, Shishu K Suman, Naveen Kumar, Amit K Sharma, Jeyachitra Amirdhanayagam, Haladhar D Sarma, Drishty Satpati, Tapas Das
肿瘤
其它细胞
发表日期：2022
文献求助 收藏

Synthesis and comparative evaluation of (177)Lu-labeled PEG and non-PEG variant peptides as HER2-targeting probes

合成和比较评价（177）Lu标记的PEG和非PEG变体肽作为HER2靶向探针

期刊:Scientific Reports
影响因子:3.9
doi:10.1038/s41598-022-19201-9
Sharma, Amit Kumar; Sharma, Rohit; Vats, Kusum; Sarma, Haladhar Dev; Mukherjee, Archana; Das, Tapas; Satpati, Drishty
HER2
发表日期：2022
文献求助 收藏

Immunopotential of Pasteurella multocida bivalent outer membrane protein-based vaccine entrapped in aluminum hydroxide nanoparticles

包埋于氢氧化铝纳米颗粒中的多杀性巴氏杆菌二价外膜蛋白疫苗的免疫潜力

期刊:Brazilian Journal of Microbiology
影响因子:1.9
doi:10.1007/s42770-022-00795-1
Pegu, Haladhar; Tamuly, Shantanu; Sharma, Rajeev Kumar; Borah, Probodh; Nath, Rita
免疫/内分泌
发表日期：2022
文献求助 收藏

Preparation of (177)Lu-PSMA-617 in Hospital Radiopharmacy: Convenient Formulation of a Clinical Dose Using a Single-Vial Freeze-Dried PSMA-617 Kit Developed In-House

医院放射药房中 (177)Lu-PSMA-617 的制备：使用自主研发的单瓶冻干 PSMA-617 试剂盒便捷配制临床剂量

期刊:Biomed Research International
影响因子:2.3
doi:10.1155/2021/1555712
Guleria, Mohini; Amirdhanayagam, Jeyachitra; Sarma, Haladhar D; Rallapeta, Ramya Priya; Krishnamohan, V S; Nimmagadda, Ajit; Ravi, Parthasarathy; Patri, Sailaja; Kalawat, Tekchand; Das, Tapas
发表日期：2021
文献求助 收藏

Formulation and clinical translation of [177Lu]Lu-trastuzumab for radioimmunotheranostics of metastatic breast cancer

[177Lu]Lu-曲妥珠单抗的配方及临床转化用于转移性乳腺癌的放射免疫治疗

期刊:RSC Medicinal Chemistry
影响因子:4.1
doi:10.1039/d0md00319k
Mohini Guleria, Rohit Sharma, Jeyachitra Amirdhanayagam, Haladhar D Sarma, Venkatesh Rangarajan, Ashutosh Dash, Tapas Das
免疫
乳腺癌
发表日期：2020
文献求助 收藏

Targeted Tumor Therapy with Radiolabeled DNA Intercalator: A Possibility? Preclinical Investigations with (177)Lu-Acridine

利用放射性标记DNA嵌入剂进行靶向肿瘤治疗：一种可能性？(177)Lu-吖啶的临床前研究

期刊:Biomed Research International
影响因子:2.3
doi:10.1155/2020/9514357
Ghosh, Subhajit; Das, Tapas; Suman, Shishu K; Kumar, Chandan; Sarma, Haladhar D; Dash, Ashutosh
肿瘤
肿瘤免疫
发表日期：2020
文献求助 收藏

Preparation and evaluation of (99m)Tc-labeled porphyrin complexes prepared using PNP and HYNIC cores: studying the effects of core selection on pharmacokinetics and tumor uptake in a mouse model

制备和评价以PNP和HYNIC为核的(99m)Tc标记卟啉配合物：研究核选择对小鼠模型中药代动力学和肿瘤摄取的影响

期刊:Medchemcomm
影响因子:
doi:10.1039/c8md00559a
Guleria, Mohini; Das, Tapas; Vats, Kusum; Amirdhanayagam, Jeyachitra; Mathur, Anupam; Sarma, Haladhar D; Dash, Ashutosh
肿瘤
肿瘤免疫
发表日期：2019
文献求助 收藏

Preparation and clinical translation of (99m)Tc-PSMA-11 for SPECT imaging of prostate cancer

(99m)Tc-PSMA-11 的制备及在 SPECT 成像诊断前列腺癌中的临床转化

期刊:Medchemcomm
影响因子:
doi:10.1039/c9md00401g
Vats, Kusum; Agrawal, Kanhaiyalal; Sharma, Rohit; Sarma, Haladhar Dev; Satpati, Drishty; Dash, Ashutosh
肿瘤
前列腺癌
肿瘤免疫
发表日期：2019
文献求助 收藏

Studies towards elucidating the potential of 5,10,15,20-tetrakis(p-carboxy-methyleneoxyphenyl)porphyrin as a theranostic agent for applications in PET and PDT

研究旨在阐明5,10,15,20-四(对羧基亚甲氧基苯基)卟啉作为PET和PDT治疗诊断剂的潜力。

期刊:Medchemcomm
影响因子:
doi:10.1039/c7md00433h
Guleria, Mohini; Kumar, Chandan; Das, Tapas; Amirdhanayagam, Jeyachitra; Sharma, Rohit; Sarma, Haladhar D; Dash, Ashutosh
发表日期：2018
文献求助 收藏

(68)Ga-Chelation and comparative evaluation of N,N'-bis-[2-hydroxy-5-(carboxyethyl)benzyl]ethylenediamine-N,N'-diacetic acid (HBED-CC) conjugated NGR and RGD peptides as tumor targeted molecular imaging probes

（68）Ga螯合和N,N'-双-[2-羟基-5-(羧乙基)苄基]乙二胺-N,N'-二乙酸（HBED-CC）偶联的NGR和RGD肽作为肿瘤靶向分子成像探针的比较评价

期刊:Medchemcomm
影响因子:
doi:10.1039/c7md00006e
Satpati, Drishty; Sharma, Rohit; Kumar, Chandan; Sarma, Haladhar Dev; Dash, Ashutosh
肿瘤
肿瘤免疫
发表日期：2017
文献求助 收藏